NMI — Aladdin Healthcare Technologies SE Share Price
Last trade - 00:00- €0.02m
- €2.16m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.04 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -6.71% | ||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | -72.98 | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aladdin Healthcare Technologies SE is a Germany based provider of health care services with the help of Artificial Intelligence. It operates as a healthcare technology company, which develops and builds AI technology diagnostics and health screening services such as blood testing, advanced image processing, and analysis of age-related diseases. The Company serves clients worldwide.
Directors
- Last Annual
- December 31st, 2020
- Last Interim
- June 30th, 2021
- Incorporated
- July 17th, 2014
- Public Since
- November 2nd, 2018
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Dusseldorf Stock Exchange
- Shares in Issue
- 11,458,238
- Address
- Unter den Linden 10, BERLIN, 10117
- Web
- https://aladdinid.com/de/
- Phone
- +49 30700140449
- Auditors
- Warth & Klein Grant Thornton AG
Similar to NMI
Limes Schlosskliniken AG
Dusseldorf Stock Exchange
FAQ
As of Today at 19:01 UTC, shares in Aladdin Healthcare Technologies SE are trading at €0.00. This share price information is delayed by 15 minutes.
Shares in Aladdin Healthcare Technologies SE last closed at €0.00 and the price had moved by -70% over the past 365 days. In terms of relative price strength the Aladdin Healthcare Technologies SE share price has underperformed the FTSE Global All Cap Index by -71.84% over the past year.
There is no consensus recommendation for this security.
Aladdin Healthcare Technologies SE does not currently pay a dividend.
Aladdin Healthcare Technologies SE does not currently pay a dividend.
Aladdin Healthcare Technologies SE does not currently pay a dividend.
To buy shares in Aladdin Healthcare Technologies SE you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €0.00, shares in Aladdin Healthcare Technologies SE had a market capitalisation of €0.02m.
Here are the trading details for Aladdin Healthcare Technologies SE:
- Country of listing: Germany
- Exchange: DUS
- Ticker Symbol: NMI
Based on an overall assessment of its quality, value and momentum Aladdin Healthcare Technologies SE is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aladdin Healthcare Technologies SE. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -13.01%.
As of the last closing price of €0.00, shares in Aladdin Healthcare Technologies SE were trading -20.63% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Aladdin Healthcare Technologies SE PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Aladdin Healthcare Technologies SE's management team is headed by:
- Wade Menpessmith - CHM
- Bimal Shah - VCH
- Hamish Badenoch - DRC